#CRISPR

Transgenic Plant -2

Major advantage of CRISPR over ZFN/TALEN is:

Major advantage prompting global adoption of CRISPR over zinc finger nucleases and TALEN is unparalleled ease of design, cloning and deployment reducing cost and technical expertise barrier. ZFN construction involves library of zinc finger modules each specific for 5'GNN 3' triplet; assembly of three to six modules suffers from context dependence where finger-finger junctions alter specificity requiring selection via bacterial two-hybrid or OPEN platforms taking months and low success rates for AT-rich targets. TALEN improves modularity with simple RVD code but still demands assembly of 15-20 repeat plasmids via Golden Gate requiring multiple ligations, sequence verification, 5-7 days per TALEN, limited by repeat instability in E. coli due to homologous recombination. CRISPR eliminates protein engineering entirely: chemically synthesized pair of oligonucleotides encoding 20 nt spacer annealed and ligated into guide RNA expression vector or synthesized as single guide RNA ribonucleoprotein complex ready for transfection electroporation within one day. No protein evolution. Commercial kits provide optimized SpCas9 protein, high-fidelity variants, base editors. Consequently labs worldwide adopted CRISPR for gene knockout, knockin, activation, leading to over 10000 publications yearly, crop edits and two Nobel prize.

Ref: Hsu et al. Cell 2014 157:1262 CRISPR ease vs ZFN TALEN; Zhang Feng Nat Protocols ease design.

View Details

Transgenic Plant -2

Genome editing method most precise at predetermined site is:

Precision of genome editing methods varies drastically correlating with targeting mechanism. Random mutagenesis approaches such as TILLING based on EMS alkylation of guanine causing G to A transitions genome-wide at ~1 per 150 kb requires screening massive populations via CEL1 nuclease assay and mapping; transposon mutagenesis with Ac/Ds or Mutator inserts at TA dinucleotides semi-randomly within genes, excision leaves footprint and instability; T-DNA insertion via Agrobacterium integrates preferentially into euchromatic gene rich regions at 5'-UTRs causing large deletions and chromosomal rearrangements. All three generate unpredictable background mutations complicating breeding. CRISPR/Cas9 provides defined precision at predetermined site because single guide RNA 20 nt dictates cleavage 3 bp upstream of PAM NGG via Watson-Crick base pairing, enabling base editors fusing deactivated Cas9 to deaminases for A to G or C to T changes without DSB, prime editors for insertions. Multiplexing with several guides edits multiple loci simultaneously without crossing. Whole genome sequencing confirms minimal off-targets when high-fidelity Cas9 variants like SpCas9-HF1 employed. This site-specific precision revolutionized crop trait stacking and therapeutic editing for sickle cell disease correcting point mutation.

Ref: Doudna Charpentier Science 2014 CRISPR precision; Voytas Plant Cell 2013 Editing comparison.

View Details

Gene Therapy

CRISPR, ZFN and TALEN are used in gene therapy for:

CRISPR-Cas9, ZFN, TALEN constitute programmable site-specific endonucleases enabling precise genome manipulation. CRISPR uses single-guide RNA 20 nt spacer complementary to genomic target adjacent NGG PAM recognized Streptococcus pyogenes Cas9 possessing HNH domain cleaving complementary strand RuvC noncomplementary generating blunt double-strand break 3 bp upstream PAM. Zinc-finger arrays modules each recognizing 3 bp triplets linked FokI nuclease dimerize cutting within spacer, while TALEN repeats repeat-variable di-residues HD recognizing cytosine NI adenine NG thymine NN guanine provide single-base flexibility. Cellular repair via error-prone nonhomologous end-joining introduces indels knocking out CCR5 for HIV resistance, while homology-directed repair donor template 400 bp homology arms flanking break precisely corrects sickle HBB glutamate 6 valine mutation or inserts therapeutic transgene into safe harbor AAVS1 chromosome 19 constitutive expression under endogenous promoter. Permanent genomic alteration distinguishes editing from transient augmentation offering curative potential single intervention approved exagamglogene autotemcel for sickle cell. This mechanistic insight guides vector optimization, dosing strategies, and clinical safety monitoring essential for translational development and regulatory evaluation.

Ref: NIH Genome Editing CRISPR ZFN TALEN Overview; Nature Biotech Comparison 2020; NCBI Gene Editing Therapy https://www.ncbi.nlm.nih.gov/books/NBK542207/.

View Details

Gene regulation in Prokaryotes

CRISPR provides bacteria with

CRISPR-Cas systems confer heritable sequence-specific defense fundamentally distinct from innate restriction-modification. Following initial infection, adaptation complex Cas1-Cas2 captures viral or plasmid protospacer DNA and integrates new spacer into leader-proximal end of CRISPR array. Upon reinfection, array transcribed and processed into crRNAs that guide Cas nucleases to complementary invader DNA or RNA for targeted cleavage. Spacer acquisition creates immunological memory improving resistance with repeated encounters, fulfilling criteria for Lamarckian inheritance. This adaptive character underpins repurposing for genome editing, while providing bacteria population-level immunity, spacer diversity, and protection against lytic phages preserving microbial ecosystems.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 5: CRISPR – Adaptive Immunity in Prokaryotes

View Details

Gene Tar getting

Which platform has lowest off-target mutation rate?

Off-target mutations determine safety for therapeutic genome editing. CRISPR tolerates mismatches distal to PAM generating relatively higher off-target cleavage. ZFNs and TALENs show lower tolerance due to longer protein-DNA interface and requirement for dimerization, yet still recognize near cognate sites. Homing endonucleases or meganucleases like I-SceI recognize 18-24 base pair asymmetric sequences, often exceeding 20 base pairs of specificity, resulting in rarity of cognate site in complex genome and extremely low off-target rate. Their long recognition site accounts for highest specificity among editing nucleases.

Ref: NCERT Biology Class XII Principles on Klenow fill-in labeling, Lehninger Chapter 9 DNA cloning techniques, and Molecular Cloning by Sambrook Chapter 10 documenting end-labeling of cohesive termini.

View Details

Gene Tar getting

Cas9 endonuclease cuts the DNA and creates:

Cas9 is dual nuclease utilizing HNH domain to cut target strand complementary to guide RNA and RuvC domain to cut non-target strand simultaneously. Both nicks occur three base pairs upstream of PAM on opposite strands, generating predominantly blunt ended double strand breaks without single stranded overhangs. Such blunt breaks are predominantly repaired by non-homologous end joining causing small indels, or by homology directed repair if donor template provided. Blunt nature facilitates efficient ligation mediated insertion and predictable editing outcomes in genome engineering laboratories worldwide.

Ref: NCERT Biology Class XII Principles on Klenow fill-in labeling, Lehninger Chapter 9 DNA cloning techniques, and Molecular Cloning by Sambrook Chapter 10 documenting end-labeling of cohesive termini.

View Details